Nokhodian Zary, Yazdani Mohammad Reza, Yaran Majid, Shoaei Parisa, Mirian Mina, Ataei Behrooz, Babak Anahita, Ataie Mehdi
Infectious Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran.
Hepat Mon. 2012 Jul;12(7):442-7. doi: 10.5812/hepatmon.6144. Epub 2012 Jul 30.
Female prisoners are at risk of acquiring sexually transmitted infections (STIs). There has been no previous study regarding the epidemiological status of STIs among female prisoners in Isfahan, central Iran.
The aim of this study was to investigate the prevalence and risk factors of the aforementioned infections among women incarcerated in the central prison, Isfahan, to determine appropriate prevention measures.
In a cross-sectional study, all of the 163 women incarcerated in the central prison, Isfahan in 2009, were voluntarily enrolled by the census method. After completing a checklist consisting of demographic, social, and risk factors, a 5ml blood sample was taken from each individual. The sera were analyzed for markers of the hepatitis B virus (HBV; HBsAg, HBsAb, HBcAb), hepatitis C virus (HCV; HCV antibodies), human immunodeficiency virus (HIV; HIV antibodies), and syphilis (RPR). Confirmatory tests were performed on HCV antibody-positive cases.
The mean age of the participants in the study was 34.54 ± 11.2 years old, 94.3% of these women were Iranian, and many of them had only a primary level of education. The prevalence of HBsAg, HBcAb, HBsAb, and HCV antibodies were; 1.2%, 7.4%, 12.9% and 7.4% respectively. No positive RPR or HIV antibodies were detected.
A significant relationship was seen between the HCV antibody, drug injection and illegal sex in the women, and also between HBc-Ab and drug injection. Regular screening, educational programs, and facilitation of access to suitable treatment care should be widely implemented in the prison population. Testing for immunity against HBV should be considered on admission, and afterwards vaccination of all prisoners and an appropriate preventative approach should be applied.
女性囚犯有感染性传播感染(STIs)的风险。此前尚无关于伊朗中部伊斯法罕女性囚犯中性传播感染流行病学状况的研究。
本研究旨在调查伊斯法罕中央监狱女性囚犯中上述感染的患病率及危险因素,以确定适当的预防措施。
在一项横断面研究中,采用普查方法自愿纳入了2009年被关押在伊斯法罕中央监狱的所有163名女性。在完成一份包含人口统计学、社会和危险因素的清单后,从每个人身上采集5毫升血液样本。对血清进行乙型肝炎病毒(HBV;HBsAg、HBsAb、HBcAb)、丙型肝炎病毒(HCV;HCV抗体)、人类免疫缺陷病毒(HIV;HIV抗体)和梅毒(RPR)标志物分析。对HCV抗体阳性病例进行确证试验。
研究参与者的平均年龄为34.54±11.2岁,其中94.3%为伊朗人,且她们中许多人只有小学文化程度。HBsAg、HBcAb、HBsAb和HCV抗体的患病率分别为1.2%、7.4%、12.9%和7.4%。未检测到RPR或HIV抗体阳性。
女性中HCV抗体、药物注射与非法性行为之间以及HBc - Ab与药物注射之间存在显著关联。应在监狱人群中广泛开展定期筛查、教育项目,并促进获得适当的治疗护理。入狱时应考虑检测乙肝病毒免疫力,之后应对所有囚犯进行疫苗接种并采取适当的预防措施。